CETP rs1800977: Understanding the TaqIB Polymorphism
The rs1800977 variant, widely known as the TaqIB polymorphism, is a genetic change located within the CETP gene. It is frequently studied for its statistical association with circulating high-density lipoprotein cholesterol (HDL-C) levels and its potential influence on cardiovascular health profiles.
What each genotype means
Higher HDL-C levels
This genotype is historically referred to as the B2B2 genotype in scientific literature. Research indicates that individuals with this genotype often exhibit lower CETP activity and higher circulating levels of high-density lipoprotein cholesterol (HDL-C) compared to those with the GG genotype.
This genotype is common, with the A allele (often called the B2 allele) appearing at a frequency of approximately 0.40 to 0.45 across many global populations.
Intermediate HDL-C profile
This genotype represents a heterozygous state, often referred to as the B1B2 genotype. Individuals with this profile typically show intermediate levels of CETP activity and HDL-C concentrations compared to the homozygous groups.
This is a very common genotype, found in a significant portion of the population across diverse continental groups.
Lower HDL-C levels
This genotype is historically referred to as the B1B1 genotype. Research suggests that individuals with this genotype generally have higher CETP activity and lower circulating levels of high-density lipoprotein cholesterol (HDL-C) compared to those carrying the A allele.
This genotype is common, as the G allele (often called the B1 allele) is frequently observed in most human populations.
What is the rs1800977 Variant?
The rs1800977 variant is a single nucleotide polymorphism (SNP) situated within the first intron of the CETP gene. In genetic literature, this specific site is historically referred to as the TaqIB polymorphism. Because it is located in an intron—a non-coding region of the gene—it does not directly alter the amino acid sequence of the protein produced by the gene. Instead, researchers investigate it as a marker that may influence how the gene is regulated or expressed. The variant is defined by two common alleles, often labeled in older literature as B1 and B2, which correspond to the presence or absence of a specific restriction enzyme cut site. By studying this location, scientists aim to understand how subtle variations in our DNA sequence correlate with measurable differences in blood lipid profiles across diverse human populations.
The Role of the CETP Gene
The CETP gene provides instructions for creating the cholesteryl ester transfer protein. This protein plays a central role in lipid metabolism by facilitating the transfer of cholesteryl esters from high-density lipoprotein (HDL) particles to other lipoproteins, such as low-density lipoprotein (LDL) and very-low-density lipoprotein (VLDL). By moving cholesterol between these particles, CETP effectively modulates the composition of circulating lipids. Because HDL is often associated with the transport of cholesterol away from tissues and toward the liver, the activity of the CETP protein is a key factor in maintaining lipid balance. When CETP activity is reduced, it can lead to higher levels of HDL cholesterol in the blood. Understanding this mechanism is essential for interpreting why variations in the CETP gene are so frequently examined in the context of cardiovascular research.
Research Associations and Evidence
Research into rs1800977 has consistently shown a statistical association between the variant and variations in HDL-C levels. Specifically, the B2 allele is often associated with lower CETP activity and, consequently, higher circulating HDL-C levels compared to the B1 allele. While these associations are well-documented, the clinical implications remain a subject of ongoing scientific discussion. Some studies suggest that the variant may influence cardiovascular risk profiles, but the evidence is considered limited or mixed. Factors such as diet, smoking status, and underlying health conditions like diabetes can interact with this genetic background, potentially masking or amplifying the variant's effects. Because cardiovascular health is complex and influenced by many genes and environmental factors, this SNP should be viewed as one small piece of a much larger biological puzzle rather than a definitive predictor of health outcomes.
Population Frequency
The rs1800977 variant is common across many global populations. The minor allele frequency is generally observed to be between 0.40 and 0.45 across diverse continental groups, meaning that both the major and minor alleles are present at relatively high frequencies in the general population.
Interpreting Your Genetic Information
It is important to understand that genetic variants like rs1800977 provide information about biological tendencies rather than medical diagnoses. While research links this variant to differences in HDL-C levels, it does not determine your overall cardiovascular health or dictate your risk for specific diseases. Many factors, including lifestyle choices, physical activity, and other genetic markers, play a much larger role in your health. You cannot use this information to diagnose yourself or to make decisions about medication or treatment. If you have questions about your cholesterol levels or your cardiovascular risk, the most appropriate step is to consult with a qualified healthcare provider or a cardiologist. They can interpret your lipid panels in the context of your full medical history and provide guidance tailored to your specific needs. Always discuss any concerns about your health or potential treatments with a medical professional.
How common is this variant?
The rs1800977 variant is common across many global populations, with a minor allele frequency typically ranging between 0.40 and 0.45 across diverse continental groups.
Frequently asked questions
Does the rs1800977 variant cause high cholesterol?
The rs1800977 variant is associated with variations in HDL-C levels, but it is not considered a direct cause of clinical high cholesterol. Cholesterol levels are influenced by a complex combination of genetics, diet, and lifestyle factors.
Can I use this SNP to predict my heart disease risk?
No, this SNP cannot be used to predict your individual risk for heart disease. Cardiovascular risk is determined by many factors, and this variant is only one small piece of a complex biological system.
Should I change my diet based on my rs1800977 genotype?
You should not change your diet based solely on this genetic variant. Any dietary changes should be discussed with a doctor or a registered dietitian who can evaluate your overall health and nutritional needs.
Is the B2 allele always better for my health?
While the B2 allele is associated with higher HDL-C levels, 'better' is a complex term in biology. The clinical impact of this variant is still debated, and it does not guarantee protection against cardiovascular issues.
Sources & further reading
Educational information only, last refreshed 9/21/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs1800977?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in CETP
CETP promoter variant associated with preserved cognitive function, elevated HDL levels, and exceptional longevity across European cohorts.
The B2 (A) allele of the TaqIB polymorphism is associated with lower CETP activity and significantly higher HDL-cholesterol levels.
The missense variant p.Ile422Val (I405V) in CETP is associated with reduced cholesteryl ester transfer protein activity, leading to elevated HDL-C levels and modest protection against coronary artery disease.
The I405V variant in CETP is associated with altered HDL cholesterol levels and cardiovascular risk profiles.
Well-established regulatory intronic polymorphism modulating cholesteryl ester transfer protein activity and circulating HDL cholesterol levels.
The I405V coding variant in cholesteryl ester transfer protein correlates with diminished CETP mass, elevated HDL cholesterol levels, and potential longevity benefits.